We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
BARK
BARK
$101M
| $156K | ﹤0.01% |
5,878
-432
| -7% | -$10.4K |
|
3177
PDS Biotechnology
PDSB
$43.4M
| $156K | ﹤0.01% |
+31,004
| New | +$203K |
|
3178
Choiceone Financial
COFS
$510M
| $156K | ﹤0.01% |
+6,777
| New | +$157K |
|
3179
Rentokil
RTO
$12.2B
| $155K | ﹤0.01% |
+3,978
| New | +$156K |
|
|
MCHB
3180
Mechanics Bancorp
MCHB
$3.68B
| $155K | ﹤0.01% |
26,208
-33,077
| -56% | -$311K |
|
|
MACK
3181
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $155K | ﹤0.01% |
+12,566
| New | +$157K |
|
|
REP
3182
DELISTED
REPSOL YPF SA ADS(RP 1 CAP SH)
REP
| $154K | ﹤0.01% |
+10,598
| New | +$154K |
|
3183
MainStreet Bancshares
MNSB
$172M
| $154K | ﹤0.01% |
+6,795
| New | +$149K |
|
3184
Waldencast
WALD
$178M
| $154K | ﹤0.01% |
+19,895
| New | +$184K |
|
|
VIGL
3185
DELISTED
Vigil Neuroscience
VIGL
| $154K | ﹤0.01% |
+16,358
| New | +$155K |
|
3186
Bilibili
BILI
$7.84B
| $153K | ﹤0.01% |
+10,160
| New | +$186K |
|
3187
First Community Corp
FCCO
$322M
| $153K | ﹤0.01% |
+8,831
| New | +$162K |
|
3188
Humacyte
HUMA
$194M
| $153K | ﹤0.01% |
53,512
+4,400
| +9% | +$15.9K |
|
|
RBOT
3189
DELISTED
Vicarious Surgical
RBOT
| $152K | ﹤0.01% |
2,771
+447
| +19% | +$28.5K |
|
|
ITI
3190
DELISTED
Iteris, Inc.
ITI
| $152K | ﹤0.01% |
+38,297
| New | +$171K |
|
|
HSHP
3191
Himalaya Shipping
HSHP
$748M
| $151K | ﹤0.01% |
+27,241
| New | +$154K |
|
3192
Eve Holding
EVEX
$962M
| $151K | ﹤0.01% |
+14,435
| New | +$120K |
|
3193
Pioneer Bancorp
PBFS
$434M
| $150K | ﹤0.01% |
16,801
-374
| -2% | -$3.27K |
|
|
DZSI
3194
DELISTED
DZS Inc. Common Stock
DZSI
| $150K | ﹤0.01% |
37,836
+11,768
| +45% | +$69K |
|
3195
Beyond Air
XAIR
$3.86M
| $150K | ﹤0.01% |
+88
| New | +$201K |
|
|
AOMR
3196
Angel Oak Mortgage REIT
AOMR
$209M
| $150K | ﹤0.01% |
18,166
-376
| -2% | -$2.9K |
|
|
XOMA
3197
DELISTED
Xoma
XOMA
| $149K | ﹤0.01% |
+7,884
| New | +$148K |
|
|
PARAA
3198
DELISTED
Paramount Global Class A
PARAA
| $147K | ﹤0.01% |
+7,918
| New | +$164K |
|
3199
Lineage Cell Therapeutics
LCTX
$274M
| $147K | ﹤0.01% |
+104,087
| New | +$144K |
|
3200
HighPeak Energy
HPK
$910M
| $147K | ﹤0.01% |
13,466
+3,825
| +40% | +$64.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.